Source: International Congress 2015 – Sarcoidosis: pathogenesis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dingyuan Jiang (Beijing, China), Dingyuan Jiang, Jing Geng, Zheng Liu, Min Zhu, Xiaofen Zheng, Huaping Dai. Inhibited IL-17A ameliorates sarcoid-like granulomatosis in mice. Eur Respir J 2015; 46: Suppl. 59, 3310

Member's Comments

No comment yet.

Related content which might interest you: Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Repeated boost with propionibacterium acnes induce pulmonary fibrosis following sarcoidosis in C57BL/6 mice Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Existence of “IgG4-related pleuritis” and its clinical features Source: Annual Congress 2013 –Treatment of asthma Year: 2013 An animal model for granulomatosis with polyangiitis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Specific activation of non-classical Th1 cells in pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Atypical variants of clinical course of sarcoidosis Source: International Congress 2014 – ILDs 6 Year: 2014 Pulmonary granuloma infiltration in sarcoidosis, inflamatory markers and domestic exposure to fungi Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Are there any predictors of MTX response in progressive pulmonary sarcoidosis? Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 iNKT cells are inversely related to β-glucan in BALF and granuloma formation in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Sarcoidosis related to interferon and ribavirin treatment of hepatitis C – Analysis of four cases Source: International Congress 2014 – Sarcoidosis Year: 2014 Case presentation: Should we always treat IgG4-related lung disease? Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Functional influence of FcγRIIa on CR3 in the etiopathogenesis of sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study Source: International Congress 2014 – Sarcoidosis Year: 2014 Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases Source: International Congress 2014 – ILDs 6 Year: 2014 Childhood pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Lipoxin (LXA4) as a novel therapy for idiopathic pulmonary fibrosis Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 An atypical presentation of granulomatosis with polyangiitis (GPA) with pituitary involvement Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study Source: International Congress 2014 – Sarcoidosis Year: 2014